Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.

Gambhir M, Bockarie M, Tisch D, Kazura J, Remais J, Spear R, Michael E.

BMC Biol. 2010 Mar 17;8:22. doi: 10.1186/1741-7007-8-22.

PMID:
20236528
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.

Gambhir M, Michael E.

PLoS One. 2008 Aug 6;3(8):e2874. doi: 10.1371/journal.pone.0002874.

PMID:
18716676
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Vector transmission heterogeneity and the population dynamics and control of lymphatic filariasis.

Michael E, Gambhir M.

Adv Exp Med Biol. 2010;673:13-31. Review.

PMID:
20632527
[PubMed - indexed for MEDLINE]
5.

The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.

Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ.

PLoS Negl Trop Dis. 2008;2(12):e344. doi: 10.1371/journal.pntd.0000344. Epub 2008 Dec 9.

PMID:
19065257
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.

Bockarie MJ, Alexander ND, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW.

Lancet. 1998 Jan 17;351(9097):162-8.

PMID:
9449870
[PubMed - indexed for MEDLINE]
7.

Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.

Singh BK, Bockarie MJ, Gambhir M, Siba PM, Tisch DJ, Kazura J, Michael E.

PLoS One. 2013 Jun 24;8(6):e67004. doi: 10.1371/journal.pone.0067004. Print 2013.

PMID:
23826185
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.

Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM.

BMC Infect Dis. 2013 Jul 21;13:335. doi: 10.1186/1471-2334-13-335.

PMID:
23870103
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.

Sunish IP, Rajendran R, Mani TR, Munirathinam A, Dash AP, Tyagi BK.

Bull World Health Organ. 2007 Feb;85(2):138-45.

PMID:
17308735
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.

Burkot TR, Taleo G, Toeaso V, Ichimori K.

Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S61-9.

PMID:
12625919
[PubMed - indexed for MEDLINE]
11.

Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.

Rebollo MP, Bockarie MJ.

Expert Rev Anti Infect Ther. 2013 Jul;11(7):723-31. doi: 10.1586/14787210.2013.811841. Review.

PMID:
23879610
[PubMed - indexed for MEDLINE]
12.

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.

Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD.

J Infect Dis. 2003 Nov 1;188(9):1371-81. Epub 2003 Oct 31.

PMID:
14593597
[PubMed - indexed for MEDLINE]
Free Article
13.

Transmission dynamics of lymphatic filariasis: density-dependence in the uptake of Wuchereria bancrofti microfilariae by vector mosquitoes.

Snow LC, Michael E.

Med Vet Entomol. 2002 Dec;16(4):409-23.

PMID:
12510894
[PubMed - indexed for MEDLINE]
14.

Transmission models and management of lymphatic filariasis elimination.

Michael E, Gambhir M.

Adv Exp Med Biol. 2010;673:157-71. Review.

PMID:
20632536
[PubMed - indexed for MEDLINE]
15.

Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.

De Rochars MB, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ.

Am J Trop Med Hyg. 2004 Oct;71(4):466-70.

PMID:
15516644
[PubMed - indexed for MEDLINE]
Free Article
16.

Role of vector control in the global program to eliminate lymphatic filariasis.

Bockarie MJ, Pedersen EM, White GB, Michael E.

Annu Rev Entomol. 2009;54:469-87. doi: 10.1146/annurev.ento.54.110807.090626. Review.

PMID:
18798707
[PubMed - indexed for MEDLINE]
17.

[ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].

Chanteau S, Roux JF.

Bull Soc Pathol Exot. 2008 Jun;101(3):254-60. French.

PMID:
18681220
[PubMed - indexed for MEDLINE]
18.

Elimination of lymphatic filariasis: do we have the drugs to complete the job?

Bockarie MJ, Deb RM.

Curr Opin Infect Dis. 2010 Dec;23(6):617-20. doi: 10.1097/QCO.0b013e32833fdee5. Review.

PMID:
20847694
[PubMed - indexed for MEDLINE]
19.

Strategies and tools for the control/elimination of lymphatic filariasis.

Ottesen EA, Duke BO, Karam M, Behbehani K.

Bull World Health Organ. 1997;75(6):491-503. Review.

PMID:
9509621
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Lymphatic filariasis in Papua New Guinea: prospects for elimination.

Bockarie MJ, Kazura JW.

Med Microbiol Immunol. 2003 Feb;192(1):9-14. Epub 2002 Oct 15.

PMID:
12592558
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk